EDGAR Filing Documents for 0001477932-23-005629

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001477932-23-005629

Filing Date

2023-07-31

Accepted

2023-07-31 16:45:03

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	stch_sc13d.htm	SC 13D	53073
2	BUSINESS COMBINATION AGREEMENT	stch_ex991.htm	EX-99.1	636641
3	AMENDMENT NO. 1 TO BUSINESS COMBINATION AGREEMENT	stch_ex992.htm	EX-99.2	66938
4	AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT	stch_ex993.htm	EX-99.3	202596
5	POWER OF ATTORNEY OF STRATHSPEY CROWN HOLDINGS GROUP, LLC	stch_ex994.htm	EX-99.4	8621
	Complete submission text file	0001477932-23-005629.txt		969602

Mailing Address 4040 MACARTHUR BLVD. SUITE 210 NEWPORT BEACH CA 92660

Business Address 4040 MACARTHUR BLVD. SUITE 210 NEWPORT BEACH CA 92660 949-260-1700

Strathspey Crown Holdings Group, LLC (Filed by) CIK: 0001557024 (see all company filings)

IRS No.: 611688862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614

Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499

AEON Biopharma, Inc. (Subject) CIK: 0001837607 (see all company filings)